India-UK FTA Raises Concerns for Medical Device Sector
India-UK FTA Raises Concerns for Medical Device Sector
Why in the News ?
The proposed India-UK Free Trade Agreement (FTA) has alarmed domestic medical device manufacturers, who fear that Chinese products may gain duty-free access to Indian markets via the UK, bypassing tariffs and undermining India’s medtech ecosystem.
Concerns over Chinese Backdoor Entry
- Domestic manufacturers fear Chinese medical devices may be routed via the UK under the zero-tariff clause of the India-UK FTA.
- The UK is not a major medtech producer, but its supply chains could serve as conduits for third-country goods, especially from China.
- This raises alarms about potential dumping and market distortion in India’s $11 billion medtech sector.
Suggested Safeguards to Protect Domestic Industry
- Industry bodies urge strict “rules of origin”, with a minimum 55% UK content (excluding labor, packaging, and shipping).
- Suggestions include:
- 35% value-addition threshold,
- Mandatory documentation of manufacturing process,
- Clearly defined substantial transformation criteria.
- Call for periodic product review, safeguard clauses, and exclusion of vulnerable categories from zero-tariff access.
India’s Growing Strategic Medtech Sector
- India’s medical device industry is projected to grow from $11 billion to $50 billion by 2030.
- Industry stakeholders stress protecting this strategic sector while enabling genuine UK-origin products to benefit from the agreement.
Free Trade Agreements (FTAs) – Key Points●Definition: FTAs are mutual agreements between countries or blocs to reduce or eliminate trade barriers like tariffs, quotas, and standards. |